Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Red Bank › NPI 1710499462
Hospital

HMH Hospitals Corporation

HMH Hospitals Corporation was paid $26.39M by Medicaid between May 2018 and Dec 2024, across 253 billing codes. Its largest line is 99284, emergency room visit (serious) — 20% of everything it billed.

33Billing provider infoHMH HOSPITALS CORPORATION
RED BANK, NJ 07701
33aNPI1710499462assigned 11/02/2017
28Total paid$26.39M
24GClaims504,493
24DCodes billed253
24AFirst – last monthMay 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#52 of 93
Median peer was paid$30.60M
This provider vs. median0.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201829,913$1.84M
201963,264$3.90M
202054,964$3.31M
202176,106$4.23M
202295,611$4.32M
2023103,816$4.83M
2024incomplete80,819$3.97M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 20% 14,535 13,013 $5.17M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 16% 14,303 13,108 $4.31M
G0378 Hospital observation service, per hour 12% 3,012 2,613 $3.12M
S9480 Intensive outpatient psychiatric services, per diem 4.4% 1,445 1,350 $1.16M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 3.6% 1,201 720 $940K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.3% 4,169 3,795 $874K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.1% 4,147 3,953 $825K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.2% 9,698 2,063 $582K
96361 Intravenous infusion, hydration; each additional hour 2.1% 6,877 5,410 $550K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2.1% 669 628 $544K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 2.0% 2,828 1,977 $530K
96375 Therapeutic injection; each additional sequential IV push 2.0% 6,736 5,314 $522K
241 more codes
H0035 Mental health partial hospitalization, treatment, less than 24 hours 1.9% 2,514 $510K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.7% 8,355 $457K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1.4% 4,037 $362K
90832 Psychotherapy session, about 30 minutes 1.3% 3,013 $334K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.1% 2,769 $290K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1.0% 3,589 $266K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 11,052 $249K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 3,539 $233K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 7,331 $217K
99213 Doctor's office visit, returning patient (routine) <1% 1,605 $217K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 4,864 $200K
90853 Group psychotherapy (other than of a multiple-family group) <1% 5,618 $195K
70450 Computed tomography, head or brain; without contrast material <1% 3,678 $172K
76819 Fetal biophysical profile; without non-stress testing <1% 2,071 $167K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 5,099 $163K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 1,117 $153K
80053 Comprehensive metabolic panel <1% 27,345 $150K
OP370 <1% 3,534 $122K
99214 Doctor's office visit, returning patient (more involved) <1% 567 $116K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 829 $114K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 29,956 $109K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 1,964 $109K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,270 $104K
OP250 <1% 40,109 $98K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 5,318 $97K
92567 <1% 1,081 $90K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 4,332 $81K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 2,360 $80K
OP710 <1% 1,816 $74K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 903 $70K
OP272 <1% 5,296 $66K
71045 Radiologic examination, chest; single view <1% 6,675 $64K
93971 <1% 354 $57K
96367 <1% 335 $54K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,656 $54K
36415 Collection of venous blood by venipuncture <1% 25,071 $53K
97010 <1% 6,593 $48K
90791 Psychiatric diagnostic evaluation <1% 1,155 $45K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 566 $44K
71046 Radiologic examination, chest; 2 views <1% 3,075 $42K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,189 $36K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 2,206 $35K
76641 <1% 421 $34K
84484 <1% 8,171 $30K
77066 Tomosynthesis, mammo <1% 294 $30K
72125 Computed tomography, cervical spine; without contrast material <1% 700 $29K
76830 Ultrasound, transvaginal <1% 558 $28K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 245 $26K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 734 $24K
OP379 <1% 428 $23K
76813 <1% 192 $19K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 624 $19K
OP259 <1% 3,165 $19K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 371 $18K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 207 $18K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,240 $17K
90834 Psychotherapy session, about 45 minutes <1% 460 $17K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,032 $17K
97162 <1% 409 $16K
93976 <1% 150 $16K
OP258 <1% 18,747 $16K
96376 <1% 1,510 $16K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,491 $16K
85610 <1% 3,632 $15K
G0008 Administration of influenza virus vaccine <1% 405 $15K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 637 $15K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 55 $14K
97161 <1% 351 $13K
99173 <1% 623 $13K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 868 $12K
85730 <1% 3,030 $12K
OP278 <1% 13 $12K
86885 <1% 1,850 $12K
82077 <1% 3,451 $11K
81003 <1% 6,555 $11K
41899 Unlisted procedure, dentoalveolar structures <1% 28 $10K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 100 $10K
64493 <1% 14 $10K
81025 <1% 5,471 $10K
82962 <1% 4,544 $9K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 79 $9K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 154 $9K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 649 $9K
84443 Thyroid stimulating hormone (TSH) <1% 1,831 $9K
80048 Basic metabolic panel (calcium, ionized) <1% 1,511 $9K
99203 Doctor's office visit, new patient (routine) <1% 37 $9K
87070 <1% 3,558 $9K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,344 $8K
86901 <1% 2,288 $8K
83690 <1% 4,822 $8K
87040 <1% 858 $8K
81001 <1% 7,064 $8K
0012A <1% 297 $8K
86900 <1% 2,254 $8K
76642 <1% 112 $8K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,308 $7K
0011A <1% 297 $7K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,633 $7K
93970 <1% 28 $7K
88304 <1% 430 $7K
85027 <1% 1,032 $7K
OP279 <1% 505 $7K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,231 $6K
93017 <1% 13 $6K
80061 Lipid panel <1% 948 $6K
J3490 Unclassified drugs <1% 1,194 $6K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 50 $6K
83735 <1% 3,059 $6K
90715 <1% 371 $6K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,822 $6K
S9484 Crisis intervention mental health services, per hour <1% 12 $5K
0002A <1% 178 $5K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 3,932 $5K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 86 $5K
73630 <1% 420 $5K
71275 Computed tomographic angiography, chest, with contrast material <1% 70 $5K
76801 <1% 87 $5K
71250 <1% 42 $5K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 12 $5K
72110 <1% 199 $4K
0001A <1% 134 $4K
OP270 <1% 2,016 $4K
83605 <1% 1,530 $4K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,940 $4K
80143 <1% 1,434 $4K
73610 <1% 387 $4K
87088 <1% 994 $4K
90670 <1% 205 $4K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 63 $4K
80179 <1% 1,380 $4K
77065 Tomosynthesis, mammo <1% 62 $4K
97116 <1% 248 $4K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,725 $3K
J2060 Injection, lorazepam, 2 mg <1% 2,090 $3K
83880 <1% 711 $3K
C9290 Injection, bupivacaine liposome, 1 mg <1% 91 $3K
90686 <1% 774 $3K
0064A <1% 78 $3K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,543 $3K
80306 <1% 1,221 $3K
73564 <1% 146 $2K
0004A <1% 60 $2K
73030 <1% 212 $2K
0072A <1% 43 $2K
99215 Doctor's office visit, returning patient (complex) <1% 12 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 878 $2K
83789 <1% 605 $2K
0071A <1% 39 $2K
J2704 Injection, propofol, 10 mg <1% 2,721 $2K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,676 $2K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 72 $2K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 12 $2K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 26 $2K
87077 <1% 530 $2K
Q2038 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) <1% 134 $2K
85379 <1% 1,070 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,939 $2K
73130 <1% 160 $2K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 345 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 722 $2K
84703 <1% 1,052 $1K
74018 <1% 162 $1K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,585 $1K
80320 <1% 284 $1K
84702 <1% 343 $1K
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 742 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,177 $1K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 89 $994.47
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 89 $960.04
82607 <1% 58 $890.95
84145 <1% 286 $842.46
87999 <1% 378 $769.86
85651 <1% 145 $736.72
90697 <1% 14 $664.48
J0690 Injection, cefazolin sodium, 500 mg <1% 1,258 $596.38
97535 Self-care/home management training, each 15 minutes <1% 58 $549.86
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 62 $543.09
84439 <1% 107 $541.35
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 246 $534.99
90472 Immunization administration, each additional vaccine (list separately) <1% 18 $486.43
82728 <1% 88 $469.62
87420 <1% 246 $461.50
76536 <1% 12 $457.48
86140 <1% 342 $448.91
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 385 $420.50
72052 <1% 13 $415.24
87186 <1% 131 $406.87
84100 <1% 694 $381.59
82550 <1% 289 $368.72
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 510 $364.75
90677 <1% 132 $355.01
90656 <1% 165 $344.92
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 334 $334.10
73562 <1% 25 $311.07
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 144 $264.13
J3475 Injection, magnesium sulfate, per 500 mg <1% 263 $256.29
82248 <1% 44 $245.73
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 27 $227.79
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 214 $225.01
87486 <1% 26 $224.83
87581 <1% 26 $224.83
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 660 $212.90
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 740 $204.25
85652 <1% 219 $174.75
72040 <1% 15 $170.71
J7030 Infusion, normal saline solution , 1000 cc <1% 147 $153.49
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg <1% 258 $148.63
90681 <1% 28 $145.25
83550 <1% 43 $144.58
82247 <1% 33 $133.55
A9585 Injection, gadobutrol, 0.1 ml <1% 43 $129.65
73502 <1% 13 $127.88
87147 <1% 94 $122.52
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 79 $104.91
J3360 Injection, diazepam, up to 5 mg <1% 34 $76.77
C9113 Injection, pantoprazole sodium, per vial <1% 274 $76.40
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 96 $73.97
J1630 Injection, haloperidol, up to 5 mg <1% 151 $67.60
J0360 Injection, hydralazine hcl, up to 20 mg <1% 95 $55.99
87205 <1% 47 $55.81
83540 <1% 31 $39.46
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 60 $34.90
V2632 Posterior chamber intraocular lens <1% 44 $33.89
85378 <1% 25 $29.50
88300 <1% 28 $21.73
J2004 Injection, lidocaine hcl with epinephrine, 1 mg <1% 17 $12.86
73110 <1% 13 $12.50
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 121 $9.67
J1596 Injection, glycopyrrolate, 0.1 mg <1% 30 $8.39
J3480 Injection, potassium chloride, per 2 meq <1% 20 $8.21
86308 <1% 29 $6.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 14 $5.16
OP637 <1% 9,759 $4.21
85008 <1% 15 $1.20
81002 <1% 16 $1.00
J1171 Injection, hydromorphone, 0.1 mg <1% 18 $0.66
91300 <1% 252 $0.01
91301 0% 497 $0.00
91306 0% 47 $0.00
91307 0% 36 $0.00
J1815 Injection, insulin, per 5 units 0% 42 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSAWCZUK, IHOR (PRESIDENT)
Same official

Other billing entities under SAWCZUK, IHOR

Full network →
ProviderLocationPaid
HMH Hospitals CorporationHackensack, NJ$333.03M
HMH Hospitals CorporationNorth Bergen, NJ$79.26M
HMH Hospitals CorporationPerth Amboy, NJ$65.37M
HMH Hospitals CorporationBrick, NJ$49.91M
HMH Hospitals CorporationHolmdel, NJ$29.33M
HMH Hospitals CorporationOld Bridge, NJ$18.66M
HMH Hospitals CorporationBrick, NJ$575K
Hackensack Specialty Care Associates, PCHackensack, NJ$141K
Humc Medical ObservationHackensack, NJ$14K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.